Production (Stage)
Astrana Health, Inc.
ASTH
$24.29
-$0.18-0.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -62.84% | -63.86% | -65.45% | -48.94% | -18.90% |
| Total Other Revenue | 57.53% | 49.89% | 32.89% | 25.22% | 20.66% |
| Total Revenue | 54.81% | 46.72% | 29.71% | 22.76% | 19.34% |
| Cost of Revenue | 63.42% | 50.48% | 31.66% | 23.83% | 19.67% |
| Gross Profit | 11.49% | 26.25% | 19.73% | 17.55% | 17.71% |
| SG&A Expenses | 22.40% | 36.87% | 51.80% | 55.96% | 49.74% |
| Depreciation & Amortization | 59.99% | 57.36% | 46.10% | 25.28% | 6.25% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.45% | 49.39% | 33.49% | 26.32% | 21.80% |
| Operating Income | -13.63% | 5.60% | -16.13% | -14.86% | -8.01% |
| Income Before Tax | -29.67% | -10.04% | -15.83% | -7.58% | 7.61% |
| Income Tax Expenses | -15.78% | -3.45% | -38.50% | -43.12% | -21.39% |
| Earnings from Continuing Operations | -36.85% | -13.69% | 0.97% | 25.71% | 33.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2,275.13% | -336.51% | 138.96% | 125.11% | 108.79% |
| Net Income | -43.92% | -28.93% | 39.93% | 49.52% | 40.15% |
| EBIT | -13.63% | 5.60% | -16.13% | -14.86% | -8.01% |
| EBITDA | -1.32% | 14.57% | -7.21% | -9.48% | -5.90% |
| EPS Basic | -45.29% | -30.42% | 37.84% | 45.74% | 36.06% |
| Normalized Basic EPS | -35.25% | -30.59% | -6.80% | -15.52% | -15.90% |
| EPS Diluted | -45.52% | -30.91% | 37.52% | 47.66% | 38.18% |
| Normalized Diluted EPS | -35.42% | -30.79% | -6.86% | -14.81% | -14.81% |
| Average Basic Shares Outstanding | 1.22% | 0.96% | 3.92% | 4.21% | 4.52% |
| Average Diluted Shares Outstanding | 1.31% | 1.10% | 4.04% | 3.77% | 3.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.84% | -1.00% | 10.83% | 1.96% | 2.16% |